About Xlife sciences
Xlife sciences is a company based in Zurich (Switzerland) founded in 2013.. Xlife sciences has raised $62.81 million across 2 funding rounds. Xlife sciences has completed 1 acquisition, including Fuse AI. Xlife sciences offers products and services including Technology Platforms and Biotech Projects. Xlife sciences operates in a competitive market with competitors including CELLINK, Aspect Biosystems, OxSyBio, Collplant and Cyfuse, among others.
- Headquarter Zurich, Switzerland
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xlife Sciences Ltd.
-
Annual Revenue
$921.54 K (USD)-15.54as on Dec 31, 2024
-
Net Profit
$37.84 M (USD)130.37as on Dec 31, 2024
-
EBITDA
$-4.04 M (USD)16.53as on Dec 31, 2024
-
Total Equity Funding
$62.81 M (USD)
in 2 rounds
-
Latest Funding Round
$6.7 M (USD), Series C
Dec 03, 2020
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Xlife sciences
Xlife sciences is a publicly listed company on the SIX with ticker symbol XLS in Switzerland, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Xlife sciences
Xlife sciences offers a comprehensive portfolio of products and services, including Technology Platforms and Biotech Projects. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platforms for advancing life science research and commercialization projects.
Development of biotechnologies for medical needs and patient treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Xlife sciences
Xlife sciences has successfully raised a total of $62.81M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $6.7 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $6.7M
-
First Round
First Round
(25 Nov 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series C - Xlife sciences | Valuation |
investors |
|
| Nov, 2019 | Amount | Series C - Xlife sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Xlife sciences
Xlife sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fuse AI. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-enabled diagnostics for medical images are provided to radiologists.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Xlife sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xlife Sciences Comparisons
Competitors of Xlife sciences
Xlife sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CELLINK, Aspect Biosystems, OxSyBio, Collplant and Cyfuse, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
3D tissue engineering technology is developed for regenerative medicine applications.
|
|
| domain | founded_year | HQ Location |
Developer of integrated 3D printing and tissue-engineering platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Xlife Sciences
Frequently Asked Questions about Xlife sciences
When was Xlife sciences founded?
Xlife sciences was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Where is Xlife sciences located?
Xlife sciences is headquartered in Zurich, Switzerland.
Who is the current CEO of Xlife sciences?
Oliver R Baumann is the current CEO of Xlife sciences.
Is Xlife sciences a funded company?
Xlife sciences is a funded company, having raised a total of $62.81M across 2 funding rounds to date. The company's 1st funding round was a Series C of $56.1M, raised on Nov 25, 2019.
What is the annual revenue of Xlife sciences?
Annual revenue of Xlife sciences is $921.54K as on Dec 31, 2024.
What does Xlife sciences do?
Xlife Sciences was founded in 2013 and is based in Zurich, Switzerland. Focus is placed on the biotechnology sector, where therapeutics for various indications are developed, such as antibody therapies for obesity and acute lymphocytic leukemia, as well as nanovesicle therapies for arthritis. Additional services provided include 3D bioprinting and AI-based software for cancer diagnosis. Operations center on drug development and related platform services.
Who are the top competitors of Xlife sciences?
Xlife sciences's top competitors include Aspect Biosystems, Cyfuse and Collplant.
What products or services does Xlife sciences offer?
Xlife sciences offers Technology Platforms and Biotech Projects.
Is Xlife sciences publicly traded?
Yes, Xlife sciences is publicly traded on SIX under the ticker symbol XLS.
How many acquisitions has Xlife sciences made?
Xlife sciences has made 1 acquisition, including Fuse AI.
What is Xlife sciences's ticker symbol?
The ticker symbol of Xlife sciences is XLS on SIX.